Titre :

The first wave of COVID-19 did not cause longer wait times in head and neck cancer. Experience of a French expert center.

Auteur(s) :

Vanderhaegen, T. [Auteur]
Université de Lille
Hôpital Claude Huriez [Lille]
Pierache, A. [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Mortuaire, Geoffrey [Auteur]
Université de Lille
Hôpital Claude Huriez [Lille]
Rysman, B. [Auteur]
Université de Lille
Hôpital Claude Huriez [Lille]
Nicot, Romain [Auteur]
Université de Lille
Hôpital Roger Salengro [Lille]
Chevalier, D. [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers = Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Mouawad, F. [Auteur]
Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers = Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Hôpital Claude Huriez [Lille]

Titre de la revue :

European annals of otorhinolaryngology, head and neck diseases

Pagination :

261-267

Éditeur :

Elsevier Masson

Date de publication :

2022-09-29

ISSN :

1879-7296

Mot(s)-clé(s) :

Multidisciplinary tumor board
Wait time
Head and neck cancer
SARS-CoV-2
COVID-19

Discipline(s) HAL :

Sciences du Vivant [q-bio]

Résumé en anglais : [en]

BackgroundHead and neck cancers (HNC) have poor survival prognosis, as tumors are often diagnosed at advanced stages in patients consulting late. The first lockdown linked to the 1st wave of COVID-19 (Coronavirus Disease ...
Lire la suite >BackgroundHead and neck cancers (HNC) have poor survival prognosis, as tumors are often diagnosed at advanced stages in patients consulting late. The first lockdown linked to the 1st wave of COVID-19 (Coronavirus Disease 2019) disrupted consultation schedules in France.ObjectiveThe principal aim of the present study was to analyze consultation wait time in HNC during and after lockdown, in our university expert oncology reference center, to disclose any increase in treatment wait time.MethodsA single-center retrospective study included patients with a first diagnosis of HNC. Three groups were distinguished: “lockdown”, “post-lockdown”, and a “control” group (corresponding to a reference period 1 year earlier). Intervals between first oncologic consultation and multidisciplinary tumor board (FC-MTB) and between MTB and first treatment (MTB-T) were assessed.ResultsOne hundred and seven patients were included in the control group, 60 in the lockdown group and 74 in the post-lockdown group. There was no increase in median FC-MTB interval (respectively 35, 29 and 28 days) between the lockdown and post-lockdown groups compared to the control group (respectively P = 0.2298 and P = 0.0153). Likewise, there was no increase in MTB-T interval (27, 20 and 26 days respectively) (P = 0.4203).ConclusionNo increase in wait times was observed during the lockdown and post-lockdown periods in our center.Lire moins >

Langue :

Anglais

Comité de lecture :

Oui

Audience :

Internationale

Vulgarisation :

Non

Collections :

• Cancer Heterogeneity, Plasticity and Resistance to Therapies (CANTHER) - UMR 9020 - UMR 1277

Source :

Harvested from HAL